Employers in the United States are still hesitant to cover glucagon-like peptide-1 (GLP-1) drugs for weight loss, according to a recent survey report by the International Foundation of Employee Benefit…

Subscribe Now for Real-time Updates on the Latest Stories!
Healthcare Delivery Innovation: A New Era of Disruption The landscape of healthcare delivery has evolved significantly over the years, with…
The Republican party and President-elect Donald Trump have a long list of changes they want to make to public health…
Addressing these complex diseases requires not only identifying the genetic components but also unraveling how they interact with each other…
You're reading Part 5 of Coercive Care You're reading Part 5 of Coercive Care, a yearlong examination of the denial…
Optimizing Biosimilar Competition in the U.S. Market Beginning in 2023, five years after their European counterparts, patients in the United…
The recent defeat of a ballot initiative in Florida has dealt a blow to the reproductive rights movement, marking the…
The latest findings from a recent CDC report have raised concerns about the potential under-reporting of cases of H5N1 bird…
As Republicans prepare to take control of the Senate in January, a shift in power and influence on health care…
Sign in to your account